FOSTER CITY, Calif. & SHANGHAI–(BUSINESS WIRE)–Terns Pharmaceuticals, Inc., a global biopharmaceutical company focused on discovering and developing innovative therapies to treat liver disease and cancer, today announced that Erin Quirk, M.D., Chief Medical Officer, will present a corporate overview and update on the Company’s lead clinical programs at the Jefferies Virtual Healthcare Conference taking place June 2-4, 2020. Terns will present at 4:30 pm ET (1:30 p.m. PT) on June 2.
About Terns Pharmaceuticals
Terns Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company that is focused on the discovery and development of medicines for chronic liver disease and cancer. Based in China and the United States, the company is advancing a pipeline of drug candidates for the treatment of non-alcoholic steatohepatitis (NASH), primary biliary cholangitis (PBC), and cancer, across multiple modalities. Terns leverages world class expertise in disease biology, medicinal chemistry, and clinical development in order to bring promising new therapies to patients.
For more information, visit www.ternspharma.com and www.ternspharma.com.cn.
Contacts
US Media Contact:
Margaret Robinson
(415) 690-0084
China Media Contact:
Zhou Zhou
+86 13482103703
BANGKOK--(BUSINESS WIRE)--International insurance brokerage Pacific Prime has been selected as the recipient of AXA’s Top…
SINGAPORE - Media OutReach Newswire - 17 May 2024 - MoneyHero Limited (NASDAQ: MNY) ("MoneyHero"…
HONG KONG SAR - Media OutReach Newswire - 17 May 2024 - Sahm Capital, the…
OPENSTREAM HOLDINGS’ subsidiaries, Open Stream and Neutral will strengthen Accenture’s cloud, AI, smart logistics, retail…
SHANGHAI, CHINA - Media OutReach Newswire - 17 May 2024 - The Asia Pacific Enterprise…
Week-Long Showcase of Vibrant Performances from 20th to 26th May 2024 SINGAPORE - Media OutReach…